Zoe E Betteridge
Affiliation: University of Bath
- Novel autoantibodies and clinical phenotypes in adult and juvenile myositisZoe E Betteridge
Royal National Hospital for Rheumatic Diseases, NHS Foundation Trust, Upper Borough Walls, Bath, Somerset, BA1 1RL, UK
Arthritis Res Ther 13:209. 2011....
- Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesisHarsha Gunawardena
Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath Institute for Rheumatic Diseases and School for Health, University of Bath, Bath, UK
Curr Opin Rheumatol 20:675-80. 2008..This review highlights the recent work on novel myositis-specific autoantibodies, their autoantigen targets, the relationship to clinical subsets and potential role in pathogenesis...
- The diagnostic utility of autoantibodies in adult and juvenile myositisSarah L Tansley
aRoyal National Hospital for Rheumatic Diseases bUniversity of Bath, Bath, UK
Curr Opin Rheumatol 25:772-7. 2013..The purpose of this study is to review recent advances in the diagnostic utility of autoantibodies in dermatomyositis...
- Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onsetSarah L Tansley
Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Department of Pharmacy and Pharmacology, University of Bath, Department of Mathematical Sciences, University of Bath, Bath, Department of Rheumatology, Southmead Hospital, North Bristol NHS Trust, Bristol, Rheumatology Unit, University College London Institute of Child Health and Arthritis Research UK Centre for Adolescent Rheumatology at University College London, University College London Hospital and Great Ormond Street Hospital, London, UK
Rheumatology (Oxford) 53:2204-8. 2014..This study aimed to investigate the clinical associations of anti-NXP2 autoantibodies in patients with JDM stratified by age at disease onset...
- Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expressionHarsha Gunawardena
Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK
Rheumatology (Oxford) 48:607-12. 2009..In this review, we discuss the clinical utility and pathogenic significance of MSAs in disease expression...